Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics Munich, |
RCV000995873 | SCV001150257 | pathogenic | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2018-11-12 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001093196 | SCV001250055 | pathogenic | not provided | 2019-03-01 | criteria provided, single submitter | clinical testing | |
Suna and Inan Kirac Foundation Neurodegeneration Research Laboratory, |
RCV001095488 | SCV001251082 | likely benign | not specified | 2020-03-31 | criteria provided, single submitter | research | |
Laboratory for Molecular Genetic Diagnostic of Neurological Diseases, |
RCV000995873 | SCV001479302 | likely pathogenic | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2020-07-01 | criteria provided, single submitter | clinical testing | |
MGZ Medical Genetics Center | RCV000995873 | SCV002580688 | likely pathogenic | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2022-01-28 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV000995873 | SCV003919732 | pathogenic | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-04-27 | criteria provided, single submitter | clinical testing | |
Solve- |
RCV004768767 | SCV005091385 | likely pathogenic | Amyotrophic lateral sclerosis type 4 | 2022-06-01 | no assertion criteria provided | provider interpretation | Variant confirmed as disease-causing by referring clinical team |